Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002311256 | SCV000581356 | pathogenic | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2016-11-02 | criteria provided, single submitter | clinical testing | The c.7775dupC pathogenic mutation, located in coding exon 52 of the NF1 gene, results from a duplication of C at nucleotide position 7775, causing a translational frameshift with a predicted alternate stop codon (p.K2593Efs*20). This mutation has been reported in one individual with a clinical diagnosis of neurofibromatosis type 1 (Pasmant E et al. Eur. J. Hum. Genet., 2015 May;23:596-601). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Medical Genetics, |
RCV000497158 | SCV000588842 | likely pathogenic | Neurofibromatosis, type 1 | 2017-02-02 | no assertion criteria provided | clinical testing |